- Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23:186-93. doi: 10.1038/s41590-021-01122-w. PubMed PMID: 35105982.
- Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8:235. doi: 10.1038/s41392-023-01471-y. PubMed PMID: 37332039; PubMed Central PMCID: PMCPMC10277291.
- Lu X, Yamasaki S. Current understanding of T cell immunity against SARS-CoV-2. Inflamm Regen. 2022;42:51. doi: 10.1186/s41232-022-00242-6. PubMed PMID: 36447270; PubMed Central PMCID: PMCPMC9706904.
- Tziolos NR, Ioannou P, Baliou S, Kofteridis DP. Long COVID-19 Pathophysiology: What Do We Know So Far? Microorganisms. 2023;11:2458. doi: 10.3390/microorganisms11102458. PubMed PMID: 37894116; PubMed Central PMCID: PMCPMC10609046.
- Dhawan M, Rabaan AA, Fawarah MMA, Almuthree SA, Alsubki RA, Alfaraj AH, et al. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines (Basel). 2023;11:101. doi: 10.3390/vaccines11010101. PubMed PMID: 36679947; PubMed Central PMCID: PMCPMC9861463.
- Bohmwald K, Diethelm-Varela B, Rodriguez-Guilarte L, Rivera T, Riedel CA, Gonzalez PA, et al. Pathophysiological, immunological, and inflammatory features of long COVID. Front Immunol. 2024;15:1341600. doi: 10.3389/fimmu.2024.1341600. PubMed PMID: 38482000; PubMed Central PMCID: PMCPMC10932978.
- Tarique M, Suhail M, Naz H, Muhammad N, Tabrez S, Zughaibi TA, et al. Where do T cell subsets stand in SARS-CoV-2 infection: an update. Frontiers in cellular and infection microbiology. 2022;12:964265. doi: 10.3389/fcimb.2022.964265. PubMed PMID: 36034704; PubMed Central PMCID: PMCPMC9399648.
- Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023. doi: 10.1101/2023.02.09.527892. PubMed PMID: 36798286; PubMed Central PMCID: PMCPMC9934605.
- Sapir T, Averch Z, Lerman B, Bodzin A, Fishman Y, Maitra R. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. Int J Mol Sci. 2022;23:8606. doi: 10.3390/ijms23158606. PubMed PMID: 35955740; PubMed Central PMCID: PMCPMC9369212.
- Pruner KB, Pepper M. Local memory CD4 T cell niches in respiratory viral infection. J Exp Med. 2021;218:e20201733. doi: 10.1084/jem.20201733. PubMed PMID: 34160551; PubMed Central PMCID: PMCPMC8225681.
- Hermens JM, Kesmir C. Role of T cells in severe COVID-19 disease, protection, and long term immunity. Immunogenetics. 2023;75:295-307. doi: 10.1007/s00251-023-01294-9. PubMed PMID: 36752852; PubMed Central PMCID: PMCPMC9905767.
- Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25:218-25. doi: 10.1038/s41590-023-01724-6. PubMed PMID: 38212464; PubMed Central PMCID: PMCPMC10834368.
- Yunis J, Short KR, Yu D. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends Microbiol. 2023;31:644-56. doi: 10.1016/j.tim.2022.12.008. PubMed PMID: 36635162; PubMed Central PMCID: PMCPMC9829516.
- Purbey PK, Roy K, Gupta S, Paul MK. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2. Mol Immunol. 2023;156:111-26. doi: 10.1016/j.molimm.2023.03.009. PubMed PMID: 36921486; PubMed Central PMCID: PMCPMC10009586.
- Collier JL, Weiss SA, Pauken KE, Sen DR, Sharpe AH. Not-so-opposite ends of the spectrum: CD8(+) T cell dysfunction across chronic infection, cancer and autoimmunity. Nat Immunol. 2021;22:809-19. doi: 10.1038/s41590-021-00949-7. PubMed PMID: 34140679; PubMed Central PMCID: PMCPMC9197228.
- Luckheeram RV, Zhou R, Verma AD, Xia B. CD4(+)T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135. doi: 10.1155/2012/925135. PubMed PMID: 22474485; PubMed Central PMCID: PMCPMC3312336.
- Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Investig Med. 2023;71:545-62. doi: 10.1177/10815589231158041. PubMed PMID: 36879504; PubMed Central PMCID: PMCPMC9996119.
- Muller L, Di Benedetto S. From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front Immunol. 2023;14:1298004. doi: 10.3389/fimmu.2023.1298004. PubMed PMID: 37942323; PubMed Central PMCID: PMCPMC10628127.
- Chaisawangwong W, Wang H, Kouo T, Salathe SF, Isser A, Bieler JG, et al. Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2. JCI Insight. 2022;7:e158308. doi: 10.1172/jci.insight.158308. PubMed PMID: 36134660; PubMed Central PMCID: PMCPMC9675569.
- Sealy RE, Hurwitz JL. Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study. Microorganisms. 2021;9:1643. doi: 10.3390/microorganisms9081643. PubMed PMID: 34442723; PubMed Central PMCID: PMCPMC8398386.
- Lesmes-Rodríguez LC, Lambarey H, Chetram A, Riou C, Wilkinson RJ, Joyimbana W, et al. Previous exposure to common coronavirus HCoV-NL63 is associated with reduced COVID-19 severity in patients from Cape Town, South Africa. Frontiers in Virology. 2023;3:1125448. doi: 10.3389/fviro.2023.1125448.
- da Silva Antunes R, Pallikkuth S, Williams E, Dawen Yu E, Mateus J, Quiambao L, et al. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis. 2021;224:70-80. doi: 10.1093/infdis/jiab176. PubMed PMID: 33822097; PubMed Central PMCID: PMCPMC8083569.
- Tan CCS, Owen CJ, Tham CYL, Bertoletti A, van Dorp L, Balloux F. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect Genet Evol. 2021;95:105075. doi: 10.1016/j.meegid.2021.105075. PubMed PMID: 34509646; PubMed Central PMCID: PMCPMC8428999.
- Olukitibi TA, Ao Z, Warner B, Unat R, Kobasa D, Yao X. Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection. Vaccines (Basel). 2023;11:545. doi: 10.3390/vaccines11030545. PubMed PMID: 36992129; PubMed Central PMCID: PMCPMC10056353.
- Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol. 2023;23:304-16. doi: 10.1038/s41577-022-00809-x. PubMed PMID: 36539527; PubMed Central PMCID: PMCPMC9765363.
- Eggenhuizen PJ, Ooi JD. The Influence of Cross-Reactive T Cells in COVID-19. Biomedicines. 2024;12:564. doi: 10.3390/biomedicines12030564. PubMed PMID: 38540178; PubMed Central PMCID: PMCPMC10967880.
- Yang L, Caradonna TM, Schmidt AG, Chakraborty AK. Mechanisms that promote the evolution of cross-reactive antibodies upon vaccination with designed influenza immunogens. Cell Rep. 2023;42:112160. doi: 10.1016/j.celrep.2023.112160. PubMed PMID: 36867533; PubMed Central PMCID: PMCPMC10184763.
- Echaide M, Chocarro de Erauso L, Bocanegra A, Blanco E, Kochan G, Escors D. mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. Int J Mol Sci. 2023;24:5944. doi: 10.3390/ijms24065944. PubMed PMID: 36983017; PubMed Central PMCID: PMCPMC10051235.
- Tai W, Feng S, Chai B, Lu S, Zhao G, Chen D, et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nat Commun. 2023;14:2962. doi: 10.1038/s41467-023-38751-8. PubMed PMID: 37221158; PubMed Central PMCID: PMCPMC10204679.
- Spinardi JR, Srivastava A. Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination-Evidence Synthesis and Implications for New COVID-19 Vaccines. Biomedicines. 2023;11:370. doi: 10.3390/biomedicines11020370. PubMed PMID: 36830907; PubMed Central PMCID: PMCPMC9953148.
- Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, et al. T cell immune memory after covid-19 and vaccination. BMJ Med. 2023;2:e000468. doi: 10.1136/bmjmed-2022-000468. PubMed PMID: 38027416; PubMed Central PMCID: PMCPMC10668147.
- Chen B, Julg B, Mohandas S, Bradfute SB, Force RMPT. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/eLife.86015. PubMed PMID: 37140960; PubMed Central PMCID: PMCPMC10159620.
- Chen B, Julg B, Mohandas S, Bradfute SB. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12. doi: 10.7554/eLife.86015. PubMed PMID: 37140960; PubMed Central PMCID: PMCPMC10159620.
- Rotrosen E, Kupper TS. Assessing the generation of tissue resident memory T cells by vaccines. Nat Rev Immunol. 2023;23:655-65. doi: 10.1038/s41577-023-00853-1. PubMed PMID: 37002288; PubMed Central PMCID: PMCPMC10064963.
- Hartley GE, Edwards ESJ, O’Hehir RE, van Zelm MC. New insights into human immune memory from SARS-CoV-2 infection and vaccination. Allergy. 2022;77:3553-66. doi: 10.1111/all.15502. PubMed PMID: 36048132; PubMed Central PMCID: PMCPMC9538469.
- Natalini A, Simonetti S, Sher C, D’Oro U, Hayday AC, Di Rosa F. Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals. Int J Mol Sci. 2022;23:14367. doi: 10.3390/ijms232214367. PubMed PMID: 36430845; PubMed Central PMCID: PMCPMC9698736.
- Philpott JD, Miller J, Boribong BP, Charles S, Davis JP, Kazimierczyk S, et al. Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children. Cell Rep Med. 2023;4:101298. doi: 10.1016/j.xcrm.2023.101298. PubMed PMID: 38016480; PubMed Central PMCID: PMCPMC10772322.
- Yin Z, Chen JL, Lu Y, Wang B, Godfrey L, Mentzer AJ, et al. Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination. Cell Rep. 2023;42:112470. doi: 10.1016/j.celrep.2023.112470. PubMed PMID: 37141092; PubMed Central PMCID: PMCPMC10121105.
- Gilbert SC. T-cell-inducing vaccines - what’s the future. Immunology. 2012;135:19-26. doi: 10.1111/j.1365-2567.2011.03517.x. PubMed PMID: 22044118; PubMed Central PMCID: PMCPMC3246649.
- Fatima S, Ismail M, Ejaz T, Shah Z, Fatima S, Shahzaib M, et al. Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country. PLoS One. 2023;18:e0294780. doi: 10.1371/journal.pone.0294780. PubMed PMID: 37992084; PubMed Central PMCID: PMCPMC10664948.
- Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783-90. doi: 10.1016/j.vaccine.2023.02.008. PubMed PMID: 36774332; PubMed Central PMCID: PMCPMC9905096.
- Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021;398:1377-80. doi: 10.1016/S0140-6736(21)02046-8. PubMed PMID: 34534516; PubMed Central PMCID: PMCPMC8437678.
- Gao F, Mallajosyula V, Arunachalam PS, van der Ploeg K, Manohar M, Roltgen K, et al. Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8(+) T cell responses post SARS-CoV-2 infection. Immunity. 2023;56:864-78 e4. doi: 10.1016/j.immuni.2023.03.005. PubMed PMID: 36996809; PubMed Central PMCID: PMCPMC10017386.
- Jamous YF, Alhomoud DA. The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Cureus. 2023;15:e45602. doi: 10.7759/cureus.45602. PubMed PMID: 37868494; PubMed Central PMCID: PMCPMC10588549.
- Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2021;162:30-43. doi: 10.1111/imm.13262. PubMed PMID: 32935333; PubMed Central PMCID: PMCPMC7730020.
- Skarke C, Lordan R, Barekat K, Naik A, Mathew D, Ohtani T, et al. Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs. J Pharmacol Exp Ther. 2023;386:198-204. doi: 10.1124/jpet.122.001415. PubMed PMID: 37105582; PubMed Central PMCID: PMCPMC10353078.
- Abufares HI, Oyoun Alsoud L, Alqudah MAY, Shara M, Soares NC, Alzoubi KH, et al. COVID-19 Vaccines, Effectiveness, and Immune Responses. Int J Mol Sci. 2022;23:15415. doi: 10.3390/ijms232315415. PubMed PMID: 36499742; PubMed Central PMCID: PMCPMC9737588.
- Ozbay Kurt FG, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, et al. Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2. Front Immunol. 2022;13:1012526. doi: 10.3389/fimmu.2022.1012526. PubMed PMID: 36311732; PubMed Central PMCID: PMCPMC9597683.
- Lim JME, Hang SK, Hariharaputran S, Chia A, Tan N, Lee ES, et al. A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines. Cell Rep Med. 2022;3:100793. doi: 10.1016/j.xcrm.2022.100793. PubMed PMID: 36257326; PubMed Central PMCID: PMCPMC9534788.
- Fraser R, Orta-Resendiz A, Mazein A, Dockrell DH. Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines. Trends Mol Med. 2023;29:255-67. doi: 10.1016/j.molmed.2023.01.003. PubMed PMID: 36764906; PubMed Central PMCID: PMCPMC9868365.
- Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43-55. doi: 10.1016/S1473-3099(21)00460-6. PubMed PMID: 34480857; PubMed Central PMCID: PMCPMC8409907.
- Mohan A, Iyer VA, Kumar D, Batra L, Dahiya P. Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response. Life. 2023;13:2121. doi: 10.3390/life13112121. PubMed PMID: 38004261; PubMed Central PMCID: PMCPMC10672162.
- Diani S, Leonardi E, Cavezzi A, Ferrari S, Iacono O, Limoli A, et al. SARS-CoV-2-The Role of Natural Immunity: A Narrative Review. J Clin Med. 2022;11:6272. doi: 10.3390/jcm11216272. PubMed PMID: 36362500; PubMed Central PMCID: PMCPMC9655392.
- Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, et al. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study. EBioMedicine. 2023;95:104734. doi: 10.1016/j.ebiom.2023.104734. PubMed PMID: 37515986; PubMed Central PMCID: PMCPMC10404859.
- Cai C, Gao Y, Adamo S, Rivera-Ballesteros O, Hansson L, Osterborg A, et al. SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19. Sci Immunol. 2023;8:eadh0687. doi: 10.1126/sciimmunol.adh0687. PubMed PMID: 38064569; PubMed Central PMCID: PMCPMC7615587.
- Qui M, Hariharaputran S, Hang SK, Zhang J, Tan CW, Chong CY, et al. T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study. EBioMedicine. 2024;105:105203. doi: 10.1016/j.ebiom.2024.105203. PubMed PMID: 38896919; PubMed Central PMCID: PMCPMC11237860.
- Pitiriga VC, Papamentzelopoulou M, Konstantinakou KE, Theodoridou K, Vasileiou IV, Tsakris A. SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination. Vaccines (Basel). 2023;11:1186. doi: 10.3390/vaccines11071186. PubMed PMID: 37515000; PubMed Central PMCID: PMCPMC10384199.
- Maciel M, Jr., Amara RR, Bar KJ, Crotty S, Deeks SG, Duplessis C, et al. Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report. NPJ Vaccines. 2024;9:39. doi: 10.1038/s41541-024-00818-y. PubMed PMID: 38383616; PubMed Central PMCID: PMCPMC10881492.
- Jarupan M, Jantarabenjakul W, Jaruampornpan P, Subchartanan J, Phasomsap C, Sritammasiri T, et al. Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand. Vaccines (Basel). 2023;11:884. doi: 10.3390/vaccines11050884. PubMed PMID: 37242988; PubMed Central PMCID: PMCPMC10223729.
- Boretti A. mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review. Clin Exp Med. 2024;24:23. doi: 10.1007/s10238-023-01264-1. PubMed PMID: 38280109; PubMed Central PMCID: PMCPMC10821957.
- Castro Dopico X, Ols S, Lore K, Karlsson Hedestam GB. Immunity to SARS-CoV-2 induced by infection or vaccination. J Intern Med. 2022;291:32-50. doi: 10.1111/joim.13372. PubMed PMID: 34352148; PubMed Central PMCID: PMCPMC8447342.
- Naaber P, Tserel L, Kangro K, Punapart M, Sepp E, Jurjenson V, et al. Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine. Cell Rep Med. 2022;3:100716. doi: 10.1016/j.xcrm.2022.100716. PubMed PMID: 35952669; PubMed Central PMCID: PMCPMC9350667.
|